GOLD FIELDS LA CIMA S Sample Clauses

GOLD FIELDS LA CIMA S. A., a sociedad anónima incorporated and existent under the laws of Peru, with Taxpayer’s I.D. (RUC) 20507828915 and with its principal place of business at Xx. Xx Xxxxx X°000, Torre 1, Oficina 301, Urbanización Lima Polo and Xxxx Xxxx, Xxxxxxxx xx Xxxxxxxx xx Surco, Province and Department of Lima (the “Original Borrower”);
Sample 1
AutoNDA by SimpleDocs
GOLD FIELDS LA CIMA S. A. (formerly known as Sociedad Minera La Cima S.A.), a company incorporated under the laws of Peru registered at Entry A00001 of File 11606015 of the Companies Registry of Lima, with taxpayer number 20507028915 and registered office at Xx. Xxxxxx Xxxxxx Belaunde 147, Xxx Xxxxxxxxx 000, Xxxxxxx 0000, Xxx Xxxxxx, Xxxx, Xxxx (the “Borrower”);
Sample 1
GOLD FIELDS LA CIMA S. A.A., a corporation incorporated and existent under the laws of Perú, with Taxpayer’s I.D. (RUC) 20507828915, with principal place of business at Xx. Xx Xxxxx X°000, Xxxxx 0, Xxxxxxxx 1001-1002, Urbanización Lima Polo and Xxxx Club, District of Xxxxxxxx de Surco, Province and Department of Lima, represented by Xxxx Xxxx Xxxxxx Xxxxx, identified by National Identity Document (DNI) No. 00000000, and Germán Xxxxxxx Xxxxxx Belaúnde, identified by National Identity Document (DNI) No. 00000000, authorized to this end as per the powers of attorney registered in Electronic Card No. 11606015 of the Registry of Legal Entities of Lima (the “Borrower”). As Administrative Agent: • BANCO DE CRÉDITO DEL PERÚ, a corporation incorporated and existent under the laws of Perú, with Taxpayer’s I.D. (RUC) No. 20100047218, with principal place of business at Xxxxx Xxxxxxxxxx 000, Xxx. Las Xxxxxxx xx Xxxxxxxxx, District of La Molina, Province and Department of Lima, duly represented by Xxxxx Xxxxxx Xxxxxx, identified by National Identity Document (DNI) No. 00000000 and Xxxxxxx Xxxxxxxx Xxxxxxx, identified by National Identity Document (DNI) No. 00000000 authorized to this end as per the powers of attorney registered in Electronic Card No. 11009127 of the Registry of Legal Entities of Lima (the “Administrative Agent”). As Onshore Collateral Agent:
Sample 1
GOLD FIELDS LA CIMA S. A.A. Por: Nombre: [—] Cargo: [—]
Sample 1
GOLD FIELDS LA CIMA S. A. confirms that no Default is continuing or would occur as a result of [Subsidiary] becoming an Additional Borrower.]2
Sample 1

Related to GOLD FIELDS LA CIMA S

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • No Unapproved Marketing Documents The Company has not distributed and, prior to the later of any Closing Date and completion of the distribution of the Offered Shares, will not distribute any offering material in connection with the offering and sale of the Offering Shares other than any preliminary prospectus, the Final Prospectus, any Issuer Free Writing Prospectus to which the Representatives have consented in accordance with this Agreement and any Issuer Free Writing Prospectus set forth on Schedule B hereto.

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • WHEXXXX xs xxxx of a plan of reorganization, RESTART PARTNERS, L.P., a Delaware Limited Partnership ("Restart"), may acquire an ownership interest in Elsinore Corporation ("Elsinore") or the Four Queens, Inc. ("FQI");

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

Time is Money Join Law Insider Premium to draft better contracts faster.